Evidence map›Paper›PMID 37069565›Full record

ArticleBMC cancer2023

The epidemiology of multiple primary cancers in Belgium (2004-2017): Incidence, proportion, risk, stage and impact on relative survival estimates.

Gilles Macq, Geert Silversmit, Freija Verdoodt, Liesbet Van Eycken

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Role of muscle glucometabolism derived fromQuantitative imaging in medicine and surgery · 2025
    Article
  4. Review
  5. Article
  6. Decoding the mechanisms behind second primary cancers.Journal of translational medicine · 2025
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gilles MacqBelgian Cancer Registry, Rue Royale 215, box 7 1210, Brussels, Belgium.
Geert SilversmitBelgian Cancer Registry, Rue Royale 215, box 7 1210, Brussels, Belgium.
Freija VerdoodtBelgian Cancer Registry, Rue Royale 215, box 7 1210, Brussels, Belgium.
Liesbet Van EyckenBelgian Cancer Registry, Rue Royale 215, box 7 1210, Brussels, Belgium. elizabeth.vaneycken@kankerregister.org.
Institute of Natural Sciences · BE

Funding

Stichting Tegen Kanker 2019-108
6 · The paper itself

Abstract

backgroundAs both life expectancy and cancer survival improve, the incidence of multiple primary cancer has augmented and is expected to further increase. This study describes for the first time the epidemiology of multiple invasive tumours in Belgium.

methodsThis nationwide study, based on all cancers diagnosed between 2004 and 2017 in Belgium, describes the proportion of multiple primary cancer, its evolution over time, the impact of inclusion or exclusion of multiple primary cancer on relative survival estimates, the risk of developing a second primary cancer, and the difference in stage between first and second primary cancer for the same patient.

resultsThe proportion of multiple primary cancer increases with age, varies across cancer sites (from 4% for testis cancer to 22.8% for oesophageal cancer), is higher in men than in women, and has linearly increased over time. The inclusion of multiple primary cancer resulted in smaller 5-year relative survival and this impact is more pronounced in cancer sites with high relative survival. Patients with a first primary cancer have an increased risk to develop a new primary cancer compared to the population without a previous cancer history (1.27 and 1.59 times higher in men and women, respectively) and this risk depends on cancer site. Second primary cancers are associated with more advanced stages and more unknown stages than the corresponding first cancer diagnosis.

conclusionsThis study describes multiple primary cancer according to several measures (proportion, standardised incidence ratio for an second primary cancer, impact of multiple primary cancer on relative survival and differences according to stage) for the first time in Belgium. The results are based on data of a population-based cancer registry with a relatively recent onset (2004).

Indexed as

Esophageal NeoplasmsNeoplasmsNeoplasms, Multiple PrimaryNeoplasms, Second PrimaryBelgiumFemaleHumansIncidenceMaleRegistriesCancerCancer incidenceCancer stageMultiple primary cancer diagnosisRelative survivalStandardised incidence ratio

Identifiers

PMID37069565
PMCPMC10108509
OpenAlexW4366179259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.